Stay updated with breaking news from About pompe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Phase 3 data presented at WORLDSymposium reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease Paris ....